• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与前列腺癌风险相关的基因变异:全基因组关联研究的领域概述及贝叶斯方法的重新评估

Genetic variations related to the prostate cancer risk: A field synopsis and revaluation by Bayesian approaches of genome-wide association studies.

作者信息

Monteiro André Victor Oliveira, Dos Santos Naum Neves da Costa, da Silva Jonatan Pinho Rodrigues, Brasileiro Samuel Arcebispo, Botelho Juliana Campos, Sobreira Luis Eduardo Rodrigues, Leal Alessandro Luiz Araújo Bentes, Pereira Adenilson Leão, de Oliveira Ana Carolina Alves, Monteiro José Rogério Souza, da Silva Felipe Rodolfo Pereira

机构信息

Medicine College, Altamira University Campus, Federal University of Para, Altamira, PA, Brazil; Laboratory of Genetics and Medicine-Based Evidence, Altamira University Campus, Federal University of Para, Altamira, PA, Brazil.

Medicine College, Altamira University Campus, Federal University of Para, Altamira, PA, Brazil.

出版信息

Urol Oncol. 2025 Apr;43(4):270.e19-270.e28. doi: 10.1016/j.urolonc.2024.10.023. Epub 2024 Nov 26.

DOI:10.1016/j.urolonc.2024.10.023
PMID:39603876
Abstract

Prostate cancer (PCa) is a complex disease influenced by many factors, with the genetic contribution for this neoplasia having a great role in its risk. The literature brings an increased number of Genome-Wide Association Studies (GWAS's) that attempt to elucidate the genetic associations with PCa. However, these genome studies have a considerable rate of false-positive data whose results may be biased. Therefore, we aimed to apply Bayesian approaches on significant associations among polymorphisms and PCa from GWAS's data. A literature search was performed for data published before April 20, 2024, whereby two investigators used a specific combination of keywords and Boolean operators in the search ("prostate carcinoma or prostate cancer or PCa" and "polymorphism or genetic variation" and "Genome-Wide Association Study or GWAS"). The records were retrieved, and the data were extracted with further application of two different Bayesian approaches: The False Positive Report Probability (FPRP) and the Bayesian False-Discovery Probability (BFDP), both at the prior probabilities of 10 and 10. The data were considered as noteworthy at the level of FPRP <0.2 and BFDP <0.8. Besides, in-silico analyses by gene-gene network and gene enrichment were performed to evaluate the role of the noteworthy genes in PCa. As results, 13 GWAS's were included, with 2,520 values for FPRP and 1,368 values for BFDP being obtained. Our study showed an extensive number of gene variations as noteworthy candidate biomarkers for PCa risk, with highlighting for those occurred in the 8q24 locus and in the MSMB, ITGA6, SUN2, FGF10, INCENP, MLPH, and KLK3 genes.

摘要

前列腺癌(PCa)是一种受多种因素影响的复杂疾病,该肿瘤形成中的遗传因素在其发病风险中起着重要作用。文献中出现了越来越多的全基因组关联研究(GWAS),试图阐明与PCa的遗传关联。然而,这些基因组研究存在相当比例的假阳性数据,其结果可能存在偏差。因此,我们旨在将贝叶斯方法应用于GWAS数据中多态性与PCa之间的显著关联。我们对2024年4月20日前发表的数据进行了文献检索,两名研究人员在检索中使用了特定的关键词和布尔运算符组合(“前列腺癌或前列腺癌或PCa”以及“多态性或基因变异”以及“全基因组关联研究或GWAS”)。检索记录并提取数据,进一步应用两种不同的贝叶斯方法:假阳性报告概率(FPRP)和贝叶斯假发现概率(BFDP),两者的先验概率均为10和10。当FPRP<0.2且BFDP<0.8时,数据被视为值得关注。此外,通过基因-基因网络和基因富集进行了计算机分析,以评估这些值得关注的基因在PCa中的作用。结果纳入了13项GWAS,获得了2520个FPRP值和1368个BFDP值。我们的研究表明,大量基因变异是PCa风险的值得关注的候选生物标志物,尤其突出的是发生在8q24位点以及MSMB、ITGA6、SUN2、FGF10、INCENP、MLPH和KLK3基因中的变异。

相似文献

1
Genetic variations related to the prostate cancer risk: A field synopsis and revaluation by Bayesian approaches of genome-wide association studies.与前列腺癌风险相关的基因变异:全基因组关联研究的领域概述及贝叶斯方法的重新评估
Urol Oncol. 2025 Apr;43(4):270.e19-270.e28. doi: 10.1016/j.urolonc.2024.10.023. Epub 2024 Nov 26.
2
Bayesian statistical methods in genetic association studies: Empirical examination of statistically non-significant Genome Wide Association Study (GWAS) meta-analyses in cancers: A systematic review.贝叶斯统计学方法在遗传关联研究中的应用:对癌症中统计学上无显著意义的全基因组关联研究(GWAS)荟萃分析的实证检验:系统综述。
Gene. 2019 Feb 15;685:170-178. doi: 10.1016/j.gene.2018.10.057. Epub 2018 Oct 26.
3
Genetic variations in immune mediators and prostate cancer risk: A field synopsis with Bayesian calculations.免疫介质遗传变异与前列腺癌风险:基于贝叶斯计算的研究综述。
Cytokine. 2024 Jul;179:156630. doi: 10.1016/j.cyto.2024.156630. Epub 2024 May 1.
4
Gene variations related to the hepatocellular carcinoma: Results from a field synopsis and Bayesian revaluation.与肝细胞癌相关的基因变异:现场综述和贝叶斯再评估的结果。
Gene. 2023 Jun 15;869:147392. doi: 10.1016/j.gene.2023.147392. Epub 2023 Mar 24.
5
Genetic variants in migraine: a field synopsis and systematic re-analysis of meta-analyses.偏头痛中的遗传变异:领域概述和荟萃分析的系统重新分析。
J Headache Pain. 2020 Feb 11;21(1):13. doi: 10.1186/s10194-020-01087-5.
6
Polymorphisms in the interleukin genes and chronic periodontitis: A field synopsis and revaluation by Bayesian approaches.白细胞介素基因多态性与慢性牙周炎:基于贝叶斯方法的现场综述和再评价。
Cytokine. 2021 Feb;138:155361. doi: 10.1016/j.cyto.2020.155361. Epub 2020 Nov 19.
7
Genetic Variation and Autism: A Field Synopsis and Systematic Meta-Analysis.基因变异与自闭症:领域概述及系统荟萃分析
Brain Sci. 2020 Sep 30;10(10):692. doi: 10.3390/brainsci10100692.
8
Gene polymorphisms and risk of acute renal graft rejection: A field synopsis of meta-analyses and genome-wide association studies.基因多态性与急性肾移植排斥反应风险:荟萃分析和全基因组关联研究的领域综述
Transplant Rev (Orlando). 2020 Jul;34(3):100548. doi: 10.1016/j.trre.2020.100548. Epub 2020 May 11.
9
Genetic variation and systemic lupus erythematosus: A field synopsis and systematic meta-analysis.遗传变异与系统性红斑狼疮:领域综述与系统荟萃分析。
Autoimmun Rev. 2018 Jun;17(6):553-566. doi: 10.1016/j.autrev.2017.12.011. Epub 2018 Apr 7.
10
Field Synopsis and Re-analysis of Systematic Meta-analyses of Genetic Association Studies in Multiple Sclerosis: a Bayesian Approach.对多发性硬化症中遗传关联研究的系统荟萃分析进行现场概述和再分析:贝叶斯方法。
Mol Neurobiol. 2018 Jul;55(7):5672-5688. doi: 10.1007/s12035-017-0773-2. Epub 2017 Oct 12.